1. Success Story of m-TOR Inhibitors in mRCC. Mohamed Abdulla (M.D.) Prof. of Clinical Oncology Kasr Al-Aini School of Medicine Cairo University Oncology in Focus Grand Hyatt,…
Altered pharmacokinetics in liver diseases By B.Samyuktha http://pharmacy2011foru.blogspot.com/ The liver is both a synthesizing and an excreting organ. Drugs are often metabolized…